Neoadjuvant Therapy Fundamental in Triple-Negative and HER2-Positive Breast Cancer

According to a recently presented study at the 15th St. Gallen International Breast Cancer Conference held in Vienna, Austria, the use of neoadjuvant therapy revolves around achieving a pathological complete response to surgery, which has been associated with improved outcomes.